Multiplex Respiratory PCR Results in Diabetic Pneumonia Cases

Hisar Intercontinental Hospital

Status: Completed

Conditions: Multiplex Respiratory PCR Results in Diabetic Pneumonia Cases

Treatments: Diagnostic Test: multiplex respiratory polymerase chain reaction test

Study type: Observational

Funder types: Other

Identifiers

NCT06459713

HisarOD

Details and patient eligibility

About

Multiplex respiratory polymerase chain reaction (PCR) test has gained wide acceptance as an alternative to conventional culture methods for the detection of the causative agent of community-acquired pneumonia (CAP). The aim of this study is to evaluate the positivity and to determine the causative agent of CAP using multiplex respiratory PCR test in patients with diabetes mellitus.

Full description

A total of 151 adults diagnosed with CAP were enrolled. Group 1 composed of patients who had diabetes (n=42) and group 2 consisted of patients who did not have diabetes (n=109). Demographic and clinical data of the subjects were collected and compared statistically.

The multiplex respiratory PCR test positivity of group 1 was statistically higher than group 2 (p=0.004). The most identified nasopharyngeal pathogen was SARSCoV2 in group 1, whereas in group 2, the most prevalent agent was Streptococcus pneumoniae (p=0.002, p=0.628). Furthermore, the amount of procalcitonin, CRP, neutrophil counts and the ratio of neutrophil-to-lymphocyte ratio (NLR) and CRP-to-lymphocyte (CLR) ratio on admission were statistically higher in group 1 than groups 2 (p=0.012, p=0.002, p<<0.001, p=0.001, p=0.001).

Diabetic patients are at greater risk for developing CAP. Therefore, early detection and prompt treatment is crucial for diabetic patients with CAP to avoid morbidity and mortality. Multiplex respiratory PCR test is an important method for identifying the causative agent of CAP rapidly.

Enrollment: 151 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

In this study, a population of 190 people over the age of 18 were searched in terms of suitability for this work , who diagnosed with CAP after admission to the Department of Chest Diseases by using a multiplex respiratory PCR test.

Exclusion criteria

Subjects who had an infection other than pneumonia, and had a diagnosis of malignancy, transferred to intensive care unit and pregnant women were excluded.

Trial design

151 participants in 2 patient groups

Multiplex respiratory PCR test results of the groups

Description:

This single center retrospective observational study was conducted in Hisar Hospital Intercontinental between September 2021 and June 2023

Treatment:

Diagnostic Test: multiplex respiratory polymerase chain reaction test

we evaluated the importance of respiratory PCR in CAP

Description:

Subjects who had an infection other than pneumonia, and had a diagnosis of malignancy, transferred to intensive care unit and pregnant women were excluded.

Treatment:

Diagnostic Test: multiplex respiratory polymerase chain reaction test